Home Journals Articles Updates About
CN
image
收藏切换
Asymmetric synthesis of syn-aryl-(2S,3R)-2-chloro-3-hydroxy esters via an engineered ketoreductase-catalyzed dynamic reductive kinetic resolution
收藏切换
PDF
Xiaoping Yuea, Yitong Lia, Di Sangb, c, Yuan Taob, c, Zedu Huang*, b, c, Fener Chen*, a, b, c
Chinese Chemical Letters | 2023, 34(9) : 108178
Less
收藏切换
Chinese Chemical Letters | 2023, 34(9): 108178
• Communication •
Asymmetric synthesis of syn-aryl-(2S,3R)-2-chloro-3-hydroxy esters via an engineered ketoreductase-catalyzed dynamic reductive kinetic resolution
Full
Xiaoping Yuea, Yitong Lia, Di Sangb, c, Yuan Taob, c, Zedu Huang*, b, c, Fener Chen*, a, b, c
Affiliations
  • a Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, China
  • b Engineering Center of Catalysis and Synthesis for Chiral Molecules, Department of Chemistry, Fudan University, Shanghai 200433, China
  • c Shanghai Engineering Center of Industrial Asymmetric Catalysis for Chiral Drugs, Shanghai 200433, China
Published: 2023-09-15 doi: 10.1016/j.cclet.2023.108178
Outline
收藏切换

We report here a generic, green synthesis of 17 valuable syn-aryl-(2S,3R)-2–chloro-3–hydroxy esters (syn-(2S,3R)-1) in 73%-99% isolated yields along with 6.1:1–83:1 dr and 31%~ > 99% ee, through dynamic reductive kinetic resolution of racemic aryl α–chloro β-keto esters (2) catalyzed by an engineered ketoreductase which was obtained via epPCR-based directed evolution. The hectogram scale synthesis of syn-(2S,3R)-1b at a substrate concentration of 120 g/L showcased the application potential of the biocatalytic method developed presently.

(2S,3R)-2-Chloro-3-hydroxy esters  /  Dynamic reductive kinetic resolution  /  Ketoreductase  /  Directed evolution  /  Asymmetric synthesis
Xiaoping Yue, Yitong Li, Di Sang, Yuan Tao, Zedu Huang, Fener Chen. Asymmetric synthesis of syn-aryl-(2S,3R)-2-chloro-3-hydroxy esters via an engineered ketoreductase-catalyzed dynamic reductive kinetic resolution[J]. Chinese Chemical Letters, 2023 , 34 (9) : 108178 - . DOI: 10.1016/j.cclet.2023.108178
Full Text
Less
Recent years have witnessed the growing applications of ketoreductase (KRED)-catalyzed dynamic reductive kinetic resolution (DYRKR) to the asymmetric synthesis of chiral alcohols containing two adjacent stereogenic centers [1–4]. In addition to the intrinsic merits of biocatalysis including sustainability and mild operation conditions [5,6], undoubtedly this increasing popularity is mainly ascribed to the capability of predominantly forming one of the four possible stereoisomeric products in one-step, with a maximum theoretical yield of 100% [1–4]. Within this context, our group very recently performed the first systematic synthesis of various anti-aryl-(2S,3S)-2–chloro-3–hydroxy esters (anti-(2S,3S)-1, Fig. 1) through ketoreductase LfSDR1-catalyzed DYRKR of racemic aryl α–chloro β-keto esters (2), and further realized the chemo-enzymatic synthesis of the calcium channel blocker d-cis-diltiazem as wells as its structural analogs clentiazem and siratiazem [7].
Given the fact that not only anti-(2S,3S)-1, but also their diastereomers, syn-aryl-(2S,3R)-2–chloro-3–hydroxy esters (syn-(2S,3R)-1, Fig. 1) are valuable for the synthesis of pharmacologically important molecules, such as N-benzoyl-2R, 3S-3-phenyl isoserine (3), the critical structure component of taxol [8], antiplatelet agent TA-993 (4) [9,10], and the cyclic nucleotide gated channel blocker l-cis-diltiazem (5) [11–13], it is desirable to develop a generic, stereoselective synthesis of syn-(2S,3R)-1 via KRED-catalyzed DYRKR. To the best of our knowledge, the only relevant studies were ketoreductases YDL124w-, and CaADH-catalyzed highly stereoselective synthesis of syn-(2S,3R)-1a (Scheme 1), the synthetic precursor of 3 [14,15]. Notably, chemical reduction of racemic aryl α–chloro β-keto esters (2) catalyzed by chiral ruthenium complexes only furnished syn-(2S,3R)-1 with poor-to-moderate diastereoselectivities (< 9:1 dr) [16–18]. Herein, we report the enzyme identification, directed evolution, and application of the evolved variant to the asymmetric synthesis of a variety of syn-aryl-(2S,3R)-2–chloro-3–hydroxy esters via DYRKR.
In our previous study [7], we found that three ketoreductases, namely KRED-F42, KdoADH, and KRED-Bt could reduce the model substrate 2b to furnish syn-(2S,3R)-1b as the major product (Table 1, entries 1–3). Nevertheless, the diastereoselectivities were still unsatisfactory (1.1:1–6.2:1 dr). Prompted by the report that syn-(2S,3R)-1a was generated in a highly stereoselective manner through YDL124w-catalyzed reduction of 2a (Scheme 1) [14], we tested this enzyme for the reduction of 2b. To our delight, the target (2S,3R)-1b was afforded in 98.4% conversion with 46:1 dr and 98.1% ee (Table 1, entry 4). The relative syn-configuration of thus formed (2S,3R)-1b was determined based on the J2, 3 value of 6.7 Hz, whereas the absolute configuration was initially assigned according to the optical rotation data and further unambiguously confirmed by X-ray crystallography (Fig. S1 in Supporting information). Next, we purified the C-terminal-His6-tagged YDL124w and determined its specific activity towards 2b as 0.086 U/mg (Table 2). Given the moderate catalytic activity, we decided to engineer the enzyme first prior to examining the substrate scope of this biocatalytic reaction [19–21].
As a crystal structure of YDL124w is not available, we opted to invoke the error-prone PCR (epPCR) approach. Specifically, by employing the wild-type (WT) YDL124w as the template, epPCR was conducted with 0.3 mmol/L Mn2+ resulting in an average mutation rate of 1–3 amino acid substitutions. Upon screening roughly 36, 000 colonies using activity assays performed with cell-free extracts of mutant enzymes, an enzyme variant with about 20-fold increased activity towards substrate 2b was discovered. Sequence determination indicated this variant carried two mutations: S99T/F225Y. Hence, it was named as YDL124w-S99T/F225Y. The effect of different pH conditions ranging from 5.0 to 8.0, on the specific activity of the purified YDL124w-S99T/F225Y was examined, with pH 6.5 being identified as the optimal one (Fig. S2 in Supporting information). Within the temperatures between 20 ℃ and 50 ℃ tested, YDL124w-S99T/F225Y showed the highest specific activity at 30 ℃ (Fig. S3 in Supporting information). Intriguingly, assays on purified YDL124w-S99T/F225Y under optimal conditions suggested this enzyme only possessed 1.9-fold higher specific activity towards 2b relative to WT (Table 2). Furthermore, we also compared the soluble expression levels of WT and YDL124w-S99T/F225Y using the SDS-page analysis. As seen in Fig. S4 (Supporting information), this evolved enzyme variant was better solubly expressed than WT. Therefore, both the improved specific activity and the enhanced expression likely contributed to the aforementioned 20-fold increased activity in the lysate-based assays. In addition to 2b, we also determined the specific activity of WT and YDL124w-S99T/F225Y toward another two α–chloro β-keto esters 2a and 2c, because the bioreduction products of them, namely syn-(2S,3R)-1a and syn-(2S,3R)-1c, are critical synthetic intermediates to N-benzoyl-2R, 3S-3-phenyl isoserine (3) and TA-993 (4), respectively. Compared with WT, YDL124w-S99T/F225Y exhibited 1.4-fold elevated specific activity towards both 2a and 2c (Table 2).
With an improved enzyme variant YDL124w-S99T/F225Y in hand, 17 chemically-prepared aryl α–chloro β-keto esters 2 were deployed for examining its synthesis versatility at a preparative-scale (0.6 mmol) (Scheme 2). Firstly, the current bioreduction of substrates equipped with a para-substituent at the phenyl ring (2b, 2c, 2e-2j) or substrate without a substituent (2d), all occurred with high levels of stereoselectivity, regardless of the substituent's electronic property. The corresponding products syn-(2S,3R)-1 were isolated in 88%−98% yield along with 19:1–66:1 dr and 89%~ > 99% ee. In comparison, anti-(2S,3S)-1f, anti-(2S, 3S)-1g, and anti-(2S,3S)-1h, containing electron-withdrawing groups (F, Cl, Br), were synthesized with only moderate diastereoselectivities (5.3:1–9.2:1 dr) through ketoreductase LfSDR1-catalyzed DYRKR [7]. Secondly, sterically demanding substrates, including 2k and 2n with a para-phenyl and an ortho–methoxy substituent, respectively, the naphthyl-based 2l, and the bis–methoxy groups containing 2o were all reduced smoothly by YDL124w-S99T/F225Y, providing the desired products (syn-(2S,3R)-1k, syn-(2S,3R)-1n, syn-(2S,3R)-1l, and syn-(2S,3R)-1o) in good to excellent yields with excellent stereoselectivities (73%−96% yield, 20:1–83:1 dr, 95%~ > 99% ee). Thirdly, not only methyl ester, but ethyl ester 2a was accepted by YDL124w-S99T/F225Y, furnishing syn-(2S,3R)-1a in 99% yield with 44:1 dr and 94% ee. Finally, although ketone 2m with a meta–methoxy-substituted phenyl ring and heteroaryl-based substrates (2p and 2q) could be transformed to the respective chlorohydrins syn-(2S,3R)-1m, syn-(2S,3R)-1p, and syn-(2S,3R)-1q in 82%−91% yield, the diastereoselectivities were inadequate (6.1:1–10:1 dr). In the future, reaction optimization and/or protein engineering might be utilized to boost the stereoselectivity.
The application potential of the currently developed DYRKR method was further showcased by the reduction of 2b at an industrially useful concentration of 120 g/L. In our previous study of LfSDR1-catalyzed reduction of 100 g/L of 2b, a continuous fed-batch operation was necessary in order to achieve high reaction conversion, as LfSDR1 was severely inhibited by 2b at substrate concentration of 40 mmol/L or greater [7]. Fortunately, no obvious substrate inhibition was observed for YDL124w-S99T/F225Y with up to 80 mmol/L of 2b. Hence, a single-dose of 2b was employed for the current study. In practice, 2b (120 g, 120 g/L), glucose (178.5 g, 2.0 equiv.), NADP+ (149 mg, 0.2 mmol/L), methanol (100 mL), cell-free extracts of YDL124w-S99T/F225Y (corresponding to 90 g/L of wet cells), and cell-free extracts of GDH (corresponding to 3.3 g/L of wet cells) in NaPi buffer (900 mL, 100 mmol/L, pH 6.5) were stirred at 30 ℃, while maintaining the reaction pH between 6.0 and 6.5 by titrating a 4 mol/L NaOH solution. After the reaction went to nearly completion (98% conversion) as indicated by the chiral HPLC analysis, celite was added, followed by filtration. The filter cake was washed three times with ethyl acetate, and the two layers of filtrate were separated. The aqueous solution was extracted further with ethyl acetate for 2 times. Finally, the combined organic layer was washed with brine, dried, and concentrated in vacuo to give syn-(2S,3R)-1b (110.6 g, 91.4% yield) with excellent purity (93.6% chemical purity, 41:1 dr, and 98.4% ee).
Molecular docking was adopted to shed light on the molecular basis for the increased catalytic activity of YDL124w-S99T/F225Y. First of all, 3-D structure models of YDL124w and YDL124w-S99T/F225Y were built with SWISS-MODEL server [22], by using the crystal structure of the conjugated polyketone reductase C2 (CPR-C2) from Candida parapsilosis IFO 0708 as the template (PBD ID: 4H8N) [23]. The amino acid sequence identity between the wild-type YDL124w and CPR-C2 is 47%. Both models thus generated were considered as reasonable, based on the respective VERIFY [24] values of 88.8% and 88.5%, ERRAT [25] values of 92.3 and 90.9, as well as both 100% of the residues being found in the allowed region of the Ramachandran plots [26]. Then, substrate 2b was docked into the modeled structures of wild-type of YDL124w and variant YDL124w-S99T/F225Y, respectively (Fig. 2). The distance between the hydride of C4 from the nicotinamide of NADPH and the carbon atom of the carbonyl group of 2b, as well as the distance between the oxygen atom of the carbonyl group of 2b and the phenoxyl hydrogen of the catalytic residue Tyr64, were both shorter for YDL124w-S99T/F225Y than those for the wild-type enzyme (4.9 Å and 4.6 Å versus 6.1 Å and 6.2 Å). These results indicated that compared with WT, YDL124w-S99T/F225Y had higher chances to conduct both events of the hydride and the proton transfer from NADPH and Tyr64, respectively, to the carbonyl group of 2b, hence, in accordance with the improved catalytic activity of this variant determined experimentally. Finally, the two mutated residues, Ser99 and Phe225 were found to be located distal from the active site. Although at this moment it is unclear how these mutations exactly affect the catalytic activity, one possibility is that nonlocal structural perturbations occurred after mutation, thereby influencing the catalytic activity indirectly through changing the enzyme's conformational motions as well as the probability of sampling conformations conducive to catalysis [27].
In summary, epPCR-based directed evolution of ketoreductase YDL124w enabled the development of an enzyme variant, YDL124w-S99T/F225Y, exhibiting 1.4–1.9 fold enhancement of specific activity relative to the wild-type enzyme towards α–chloro β-keto esters 2a, 2b, and 2c. Compared with YDL124w, the soluble expression level of YDL124w-S99T/F225Y was much improved as well. Seventeen synthetically useful syn-aryl-(2S,3R)-2–chloro-3–hydroxy esters (syn-(2S,3R)-1) were synthesized through YDL124w-S99T/F225Y-catalyzed dynamic reductive kinetic resolution of racemic aryl α–chloro β-keto esters (2) in 73%−99% isolated yields, along with 6.1:1–83:1 dr and 31%~ > 99% ee. The practical synthesis potential of the method developed in this study was demonstrated by a nearly complete reduction of 120 g/L of 2b at a hectogram scale, furnishing syn-(2S,3R)-1b, a synthetic intermediate to the cyclic nucleotide gated channel blocker l-cis-diltiazem (5), in 91.4% isolated yield with 41:1 dr and 98.4% ee. Molecular docking was performed to help provide insights for the improvement of catalytic activity of the evolved enzyme variant.
Declaration of competing interest
Less
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Acknowledgments
Less
The National Key Research and Development Program of China (Nos. 2021YFA0911400 and 2021YFF0600704), and the National Natural Science Foundation of China (Nos. 22071033 and 21801047) are acknowledged for the financial supports.
Supplementary materials
Less
Supplementary material associated with this article can be found, in the online version, at doi:10.1016/j.cclet.2023.108178.
References
Less
[1]
G.A. Applegatea, D.B. Berkowitz, Adv. Synth. Catal. 357 (2015) 1619–1632.
[2]
Z. Li, H. Yang, J. Liu, Z. Huang, F. Chen, Chem. Rec. 21 (2017) 1611–1630.
[3]
G. Ni, J. Tang, J. Zou, et al., Chin. J. Org. Chem. 39 (2019) 339–349.
[4]
C. Huang, J. Liu, J. Fang, et al., Front. Bioeng. Biotechnol. 10 (2022) 929784.
[5]
S. Wu, R. Snajdrova, J.C. Moore, K. Baldenius, U.T. Bornscheuer, Angew. Chem. Int. Ed. 60 (2021) 88–119.
[6]
R.A.A. Sheldon, D. Brady, M.L.L. Bode, Chem. Sci. 11 (2020) 2587–2605.
[7]
X. Yue, Y. Li, M. Liu, et al., Chem. Commun. 58 (2022) 9010–9013.
[8]
I. Rimoldi, M. Pellizzoni, G. Facchetti, et al., Tetrahedron 22 (2011) 2110–2116.
[9]
M. Katoh, T. Karasawa, A. Watanabe, et al., Biol. Pharm. Bull. 24 (2001) 501–504.
[10]
H. Narita, M. Kaburaki, H. Doi, A. Yasoshima, S. Murata, Jpn. J. Pharmacol. 68 (1995) 397–404.
[11]
J.C. Gomora, J.J. Enyeart, J. Pharmacol. Exp. Ther. 290 (1999) 266–275.
[12]
L.W. Haynes, J. Gen. Physiol. 100 (1992) 783–801.
[13]
R. Shalom, L. Barki-Harrington, G. Rimon, Eur. J. Pharmacol. 543 (2006) 8–13.
[14]
B.D. Feske, I.A. Kaluzna, J.D. Stewart, J. Org. Chem. 70 (2005) 9654–9657.
[15]
G.A. Applegate, R.W. Cheloha, D.L. Nelson, D.B. Berkowitz, Chem. Commun. 47 (2011) 2420–2422.
[16]
J. Bai, S. Miao, Y. Wu, Y. Zhang, Chin. J. Chem. 29 (2011) 2476–2480.
[17]
L. Qiu, F.Y. Kwong, J. Wu, et al., J. Am. Chem. Soc. 128 (2006) 5955–5965.
[18]
L. Qiu, J. Qi, C.C. Pai, et al., Org. Lett. 4 (2002) 4599–4602.
[19]
K. Chen, F.H. Arnold, Nat. Catal. 3 (2020) 203–213.
[20]
G. Qu, A. Li, C.G. Acevedo-Rocha, Z. Sun, M.T. Reetz, Angew. Chem. Int. Ed. 59 (2020) 13204–13231.
[21]
J. Li, G. Qu, N. Shang, et al., Green Synth. Catal. 2 (2021) 45–53.
[22]
A. Waterhouse, M. Bertoni, S. Bienert, et al., Nucleic Acids Res. 46 (2018) W296–W303.
[23]
H.M. Qin, A. Yamamura, T. Miyakawa, et al., Appl. Microbiol. Biotechnol. 98 (2014) 243–249.
[24]
D. Eisenberg, R. Lüthy, J.U. Bowie, Methods Enzymol. 277 (1997) 396–404.
[25]
C. Colovos, T.O. Yeates, Protein Sci. 2 (1993) 1511–1519.
[26]
S.C. Lovell, I.W. Davis, W.B. Adrendall, et al., Proteins 50 (2003) 437–450.
[27]
K.F. Wong, T. Seizer, S.J. Benkovic, S. Hammes-Schiffer, Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 6807–6812.
Appendix
Less
Year 2023 volume 34 Issue 9
PDF
46
25
Cite this Article
BibTeX
Article Info
doi: 10.1016/j.cclet.2023.108178
  • Receive Date：2022-12-05
  • Online Date：2025-11-21
  • Published：2023-09-15
Article Data
Affiliations
History
  • Received：2022-12-05
  • Revised：2023-01-16
  • Accepted：2023-01-29
Affiliations
    a Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, China
    b Engineering Center of Catalysis and Synthesis for Chiral Molecules, Department of Chemistry, Fudan University, Shanghai 200433, China
    c Shanghai Engineering Center of Industrial Asymmetric Catalysis for Chiral Drugs, Shanghai 200433, China
References
Share
https://castjournals.cast.org.cn/joweb/ccl/EN/10.1016/j.cclet.2023.108178
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family		 属数
Number of
genus		 种数
Number of
species		 占总种数比例
Percentage of
total species (%)		 属
Genus		 种数
Number of
species		 占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT
Links
Articles
Latest Articles
Most Read
Collections
Updates
Events
News
Multimedia
About
About Us
Contact
No. 86 Xueyuan South Road, Haidian District, Beijing
100081
010-62199257
qkjq@cast.org.cn

Copyright © 2025 China Association for Science and Technology. All rights reserved. For all open access content, the relevant licensing terms apply.
Sponsored by the Office of the Leading Group for Cybersecurity and Informatization of CAST, and supported by Science and Technology Review Publishing House